Titan Pharmaceuticals
TTNP
#10405
Rank
A$9.27 M
Marketcap
A$6.97
Share price
-3.76%
Change (1 day)
34.52%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$7.12 Million, an increase over its 2023 earnings that were of -A$8.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-39.24%
2024 -A$7.12 Million-15.5%
2023 -A$8.42 Million-45.43%
2022 -A$15.44 Million16.29%
2021 -A$13.27 Million-907.36%
2020 A$1.64 M-106.6%
2019 -A$24.89 Million82.4%
2018 -A$13.65 Million-36.93%
2017 -A$21.64 Million-378.62%
2016 A$7.76 M-145.53%
2015 -A$17.06 Million369.37%
2014 -A$3.64 Million-125.9%
2013 A$14.02 M-177.74%
2012 -A$18.05 Million13.59%
2011 -A$15.89 Million74.37%
2010 -A$9.11 Million3.61%
2009 -A$8.8 Million
2007 -A$27.87 Million12.08%
2006 -A$24.87 Million-28.65%
2005 -A$34.86 Million-10.03%
2004 -A$38.74 Million-6.08%
2003 -A$41.25 Million-14.76%
2002 -A$48.39 Million32.52%
2001 -A$36.52 Million27.55%
2000 -A$28.63 Million62.5%
1999 -A$17.62 Million4.04%
1998 -A$16.94 Million49.33%
1997 -A$11.34 Million-27.88%
1996 -A$15.73 Million13.04%
1995 -A$13.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-A$0.19 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$18.16 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.39 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.97 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.82 B-585,447.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
A$39.52 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA